Adenosine A(2A) Receptor Antagonists Do Not Disrupt Rodent Prepulse Inhibition: An Improved Side Effect Profile in the Treatment of Parkinson's Disease

Parkinson's disease (PD) is characterized by loss of dopaminergic neurons in the substantia nigra. Current treatments for PD focus on dopaminergic therapies, including L-dopa and dopamine receptor agonists. However, these treatments induce neuropsychiatric side effects. Psychosis, characterized...

Descripción completa

Detalles Bibliográficos
Autores principales: Bleickardt, Carina J., LaShomb, Abigail L., Merkel, Carrie E., Hodgson, Robert A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2012
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3236485/
https://www.ncbi.nlm.nih.gov/pubmed/22191072
http://dx.doi.org/10.1155/2012/591094

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3236485/
https://www.ncbi.nlm.nih.gov/pubmed/22191072
http://dx.doi.org/10.1155/2012/591094

Ejemplares similares